Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.200 | 12 | 9001336 | intron variant | G/A | snv | 0.28 |
|
Eye Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases; Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
12 | 8948541 | intron variant | A/G | snv | 0.72 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.080 | 12 | 8949816 | upstream gene variant | A/C;G | snv | 1.7E-02 |
|
Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
12 | 9165188 | missense variant | A/G | snv | 0.32 | 0.31 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
1.000 | 0.040 | 12 | 9200312 | intron variant | C/A | snv | 0.78 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 12 | 9200312 | intron variant | C/A | snv | 0.78 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
12 | 9162261 | intron variant | T/C | snv | 0.66 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 12 | 9160708 | intron variant | A/C;G | snv |
|
Eye Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.040 | 12 | 9102864 | intron variant | T/C | snv | 1.4E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 12 | 9102864 | intron variant | T/C | snv | 1.4E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 12 | 9157342 | missense variant | C/A;G;T | snv | 1.2E-05; 3.6E-05; 3.6E-05 |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | ||||||||||
|
0.851 | 0.080 | 12 | 9079672 | missense variant | T/C | snv | 0.31 | 0.33 |
|
0.700 | 0 | ||||||||||
|
0.851 | 0.080 | 12 | 9079672 | missense variant | T/C | snv | 0.31 | 0.33 |
|
Nervous System Diseases; Mental Disorders | 0.070 | 0.714 | 7 | 1999 | 2014 | ||||||
|
12 | 9181030 | stop gained | G/A | snv | 6.6E-03 | 2.1E-03 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
12 | 9181030 | stop gained | G/A | snv | 6.6E-03 | 2.1E-03 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.080 | 12 | 9168938 | stop gained | G/A | snv | 4.3E-03 | 3.3E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||
|
0.925 | 0.080 | 12 | 9168938 | stop gained | G/A | snv | 4.3E-03 | 3.3E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||
|
1.000 | 0.080 | 12 | 9010581 | 3 prime UTR variant | A/G | snv | 0.23 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 12 | 9093581 | splice acceptor variant | ATGGT/- | delins |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.080 | 12 | 9093581 | splice acceptor variant | ATGGT/- | delins |
|
Nervous System Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.080 | 12 | 9079672 | missense variant | T/C | snv | 0.31 | 0.33 |
|
0.010 | 1.000 | 1 | 2002 | 2002 | |||||||
|
0.851 | 0.080 | 12 | 9079672 | missense variant | T/C | snv | 0.31 | 0.33 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||||
|
0.851 | 0.080 | 12 | 9079672 | missense variant | T/C | snv | 0.31 | 0.33 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||||
|
0.851 | 0.080 | 12 | 9079672 | missense variant | T/C | snv | 0.31 | 0.33 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.851 | 0.080 | 12 | 9079672 | missense variant | T/C | snv | 0.31 | 0.33 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2000 | 2000 |